title: Pharmacologic modification of radiation-induced late normal tissue injury.
authors.affiliation: Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee 53226, USA.
authors.forename: J E
authors.initials: JE
authors.lastname: Moulder
authors.forename: M E
authors.initials: ME
authors.lastname: Robbins
authors.forename: E P
authors.initials: EP
authors.lastname: Cohen
authors.forename: J W
authors.initials: JW
authors.lastname: Hopewell
authors.forename: W F
authors.initials: WF
authors.lastname: Ward
mesh_terms: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000818:Animals; D002216:Captopril / Q000627:therapeutic use*; D004730:Endothelium, Vascular / Q000187:drug effects / Q000528:radiation effects; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000528:radiation effects; D011832:Radiation Injuries / Q000188:drug therapy / Q000517:prevention & control*; D011833:Radiation Injuries, Experimental / Q000188:drug therapy / Q000517:prevention & control; D011878:Radiotherapy / Q000009:adverse effects*; D012867:Skin / Q000187:drug effects / Q000528:radiation effects
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002216:Captopril